跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AROPAX CR paroxetine 25mg (as hydrochloride hemihydrate) modified release tablet - TGA Drug Approval Details
Approvals
/
TGA
/
AROPAX CR paroxetine 25mg (as hydrochloride hemihydrate) modified release tablet
Approved
STANDARD
AROPAX CR paroxetine 25mg (as hydrochloride hemihydrate) modified release tablet
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
1f696d1bab28affa
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
1f696d1bab28affa
Product Name
AROPAX CR paroxetine 25mg (as hydrochloride hemihydrate) modified release tablet
Artg Id
101597
Artg Name
AROPAX CR paroxetine 25mg (as hydrochloride hemihydrate) modified release tablet blister pack
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
2004-05-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
1f696d1bab28affa
Type
Standard
Back to TGA Approvals